Jainex Aamcol Limited (BOM:505212)
130.25
-0.95 (-0.72%)
At close: Aug 21, 2026
Jainex Aamcol Revenue
Jainex Aamcol had revenue of 75.30M INR in the quarter ending June 30, 2026, with 15.61% growth. This brings the company's revenue in the last twelve months to 277.28M, up 13.15% year-over-year. In the fiscal year ending March 31, 2026, Jainex Aamcol had annual revenue of 267.12M with 12.29% growth.
Revenue (ttm)
277.28M
Revenue Growth
+13.15%
P/S Ratio
1.05
Revenue / Employee
2.67M
Employees
98
Market Cap
292.35M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 267.12M | 29.24M | 12.29% |
| Mar 31, 2025 | 237.87M | 28.43M | 13.58% |
| Mar 31, 2024 | 209.44M | 6.90M | 3.41% |
| Mar 31, 2023 | 202.54M | 14.87M | 7.92% |
| Mar 31, 2022 | 187.67M | 67.65M | 56.37% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Chandra Prabhu International | 5.61B |
| Polyspin Exports | 2.22B |
| Amco India | 1.24B |
| Medico Intercontinental | 845.82M |
| Gujarat Terce Laboratories | 456.22M |
| U.H. Zaveri | 443.89M |
| Sattva Sukun Lifecare | 316.78M |
| Hipolin | 160.80M |